Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 4:10 AM
Ignite Modification Date:
2025-12-25 @ 4:10 AM
NCT ID:
NCT00516620
Eligibility Criteria:
Inclusion Criteria:
* residents of households within the City of Toronto 416 calling area
* respond to advertisements in newspaper, on radio, and from flyers
* Eligible households will include at least one willing adult 18 years or older; able to communicate in English, at least one adult with BMI \>/= 25
* Pregnant and breastfeeding mothers who fit the criteria above are eligible to join the study 6 months post-partum or 6 months after the cessation of breastfeeding
* Individuals who fit the inclusion criteria but recently (past 6 months) started blood pressure medication are eligible for the study once their blood pressure is under control
* Individuals who fit the inclusion criteria but recently started hypothyroid medication or diuretics will be eligible after 1 month of treatment
Exclusion Criteria:
* Residing outside of the 416 area code
* under 18 years of age
* actively following a special diet or weight-loss program
* major cardiovascular event in the previous 6 months
* recently (past 6 months) started blood pressure medication
* diabetes, liver disease, renal failure, cancer (or a history of malignancy), inflammatory bowel disease, individuals with acute or chronic infections, either bacterial or viral, or individuals suffering from chronic inflammatory diseases, irritable bowel syndrome, peanut or nut allergy, major surgery in the previous 6 months
* blood pressure greater than 145/95 on repeated measurements will be excluded
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT00516620
Study Brief:
Protocol Section:
NCT00516620